Pharmaceuticals, Biotechnology and Life Sciences
WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that abstracts highlighting data from its oncology portfolio will be presented at the Society…
Appointment Reflects Continued Drive for Meaningful Business Impact Through Diversity and Inclusion VALLEY FORGE, Pa.–(BUSINESS WIRE)–As part of its commitment…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune…
MRx0518 demonstrates upregulation of key immune biomarkers associated with anti-cancer activity in neoadjuvant monotherapy setting Addition of new tumor type…
Provides flexible capital structure prior to anticipated period of significant innovation and growth ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR), a…
WALTHAM, Mass.–(BUSINESS WIRE)–TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology,…
WALTHAM, Mass.–(BUSINESS WIRE)–TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology,…
WALTHAM, Mass.–(BUSINESS WIRE)–TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ribon Therapeutics, a clinical-stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced the appointment of…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ribon Therapeutics, a clinical-stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced the appointment of…